先看重点
在89名中重度睡眠呼吸暂停且超重或肥胖的西班牙男性中,8周减重和生活方式干预使呼吸暂停低通气指数下降21.2次/小时,与仅接受CPAP常规治疗者相比组间差异为-23.6次/小时(95%置信区间-28.7~-18.5)。该试验为开放标签、样本小且仅限男性,结果未必适用于女性或其他人群。
证据类型
随机对照试验
解读依据
公开摘要
阅读重点
对照与不确定性
研究在问什么
肥胖是阻塞性睡眠呼吸暂停(OSA)的首要原因,但减重和生活方式干预对OSA及相关问题的作用仍不确定。作者在已使用持续气道正压通气(CPAP)的男性中检验了一项跨学科干预。
研究了谁,如何研究
2019年4月至2020年10月在西班牙格拉纳达一家医院转诊中心开展的平行组、开放标签随机临床试验(INTERAPNEA)。89名18至65岁、患中重度OSA、体重指数不低于25且正在接受CPAP治疗的男性,被随机分为常规治疗(CPAP;49人)组,或在常规治疗基础上接受为期8周的干预(40人),内容包括营养行为改变、有氧运动、睡眠卫生以及戒酒戒烟。主要结局为干预结束时及干预后6个月呼吸暂停低通气指数(AHI)的变化,次要结局包括体重和体成分、心血管代谢风险及生活质量。注册号NCT03851653。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 18周时,干预组AHI下降21.2次/小时(降幅51%;95%置信区间-25.4~-16.9),对照组上升2.5次/小时(95%置信区间-2.0~6.9),组间差异为-23.6次/小时(95%置信区间-28.7~-18.5)。
- 2干预后6个月,干预组AHI降幅为57%,组间差异为-23.8次/小时(95%置信区间-28.3~-19.3)。
- 3不再需要CPAP:干预结束时为40人中的18人(45.0%),6个月时为34人中的21人(61.8%)。OSA完全缓解:先是40人中的6人(15.0%),后为34人中的10人(29.4%)。
- 4与对照组相比,干预组在体重(-7.1 kg对-0.3 kg)、脂肪量(-2.9 kg对1.4 kg)、血压(-6.5 mm Hg对2.2 mm Hg)和睡眠呼吸暂停生活质量指数(0.8分对0.1分)方面改善也更大。
局限与不确定性
- 1仅89名男性、来自西班牙一家医院,结果未必适用于女性、其他族裔或较轻的OSA。
- 2试验为开放标签,参与者和工作人员都知道谁接受了干预。
- 36个月时干预组的随访人数(34人,基线为40人)有所减少,摘要未说明失访原因。
- 4干预由多个部分组成,摘要无法说明是哪一部分带来了获益。本解读仅基于摘要。
对日常健康的启示
对超重的男性睡眠呼吸暂停患者,结合减重、运动、睡眠习惯及减少烟酒的系统方案可能改善呼吸暂停的严重程度,但这只是一项规模较小的试验。这并不意味着可以自行停用CPAP,治疗调整应由睡眠专科医生指导。
如何联系自己的数据
如果你的可穿戴设备能估算呼吸紊乱或血氧,可以看到夜间变化趋势,但它不能代替测量AHI的睡眠监测。体重和晨起血压建议每周用同一台体重秤和血压计记录,并把趋势告诉医生。
如何理解这类证据
随机分组有助于因果推断,仍须检查分配、盲法、失访、随访时间和具体对照;标为随机试验不自动意味着高确定性。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Importance
Obesity is the leading cause of obstructive sleep apnea (OSA); however, the effects of weight loss and lifestyle interventions on OSA and comorbidities remain uncertain.
Objective
To evaluate the effect of an interdisciplinary weight loss and lifestyle intervention on OSA and comorbidities among adults with moderate to severe OSA and overweight or obesity.
Design, setting, and participants
The Interdisciplinary Weight Loss and Lifestyle Intervention for OSA (INTERAPNEA) study was a parallel-group open-label randomized clinical trial conducted at a hospital-based referral center in Granada, Spain, from April 1, 2019, to October 23, 2020. The study enrolled 89 Spanish men aged 18 to 65 years with moderate to severe OSA and a body mass index (calculated as weight in kilograms divided by height in meters squared) of 25 or greater who were receiving continuous positive airway pressure (CPAP) therapy. The sole inclusion of men was based on the higher incidence and prevalence of OSA in this population, the differences in OSA phenotypes between men and women, and the known effectiveness of weight loss interventions among men vs women.
Interventions
Participants were randomized to receive usual care (CPAP therapy) or an 8-week weight loss and lifestyle intervention involving nutritional behavior change, aerobic exercise, sleep hygiene, and alcohol and tobacco cessation combined with usual care.
Main outcomes and measures
The primary end point was the change in the apnea-hypopnea index (AHI) from baseline to the intervention end point (8 weeks) and 6 months after intervention. Secondary end points comprised changes in other OSA sleep-related outcomes, body weight and composition, cardiometabolic risk, and health-related quality of life.
Results
Among 89 men (mean [SD] age, 54.1 [8.0] years; all of Spanish ethnicity; mean [SD] AHI, 41.3 [22.2] events/h), 49 were randomized to the control group and 40 were randomized to the intervention group. The intervention group had a greater decrease in AHI (51% reduction; change, -21.2 events/h; 95% CI, -25.4 to -16.9 events/h) than the control group (change, 2.5 events/h; 95% CI, -2.0 to 6.9 events/h) at the intervention end point, with a mean between-group difference of -23.6 events/h (95% CI, -28.7 to -18.5 events/h). At 6 months after intervention, the reduction in AHI was 57% in the intervention group, with a mean between-group difference of -23.8 events/h (95% CI, -28.3 to -19.3 events/h). In the intervention group, 18 of 40 participants (45.0%) no longer required CPAP therapy at the intervention end point, and 6 of 40 participants (15.0%) attained complete OSA remission. At 6 months after intervention, 21 of 34 participants (61.8%) no longer required CPAP therapy, and complete remission of OSA was attained by 10 of 34 participants (29.4%). In the intervention vs control group, greater improvements in body weight (change, -7.1 kg [95% CI, -8.6 to -5.5 kg] vs -0.3 kg [95% CI, -1.9 to 1.4 kg]) and composition (eg, change in fat mass, -2.9 kg [95% CI, -4.5 to -1.3 kg] vs 1.4 kg [95% CI, -0.3 to 3.1 kg]), cardiometabolic risk (eg, change in blood pressure, -6.5 mm Hg [95% CI, -10.3 to -2.6 mm Hg] vs 2.2 mm Hg [95% CI, -2.1 to 6.6 mm Hg]), and health-related quality of life (eg, change in Sleep Apnea Quality of Life Index, 0.8 points [95% CI, 0.5-1.1 points] vs 0.1 points [95% CI, -0.3 to 0.4 points]) were also found at the intervention end point.
Conclusions and relevance
In this study, an interdisciplinary weight loss and lifestyle intervention involving Spanish men with moderate to severe OSA and had overweight or obesity and were receiving CPAP therapy resulted in clinically meaningful and sustainable improvements in OSA severity and comorbidities as well as health-related quality of life. This approach may therefore be considered as a central strategy to address the substantial impact of this increasingly common sleep-disordered breathing condition.
Trial registration
ClinicalTrials.gov Identifier: NCT03851653.
来源与署名
Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial.
Carneiro-Barrera A, Amaro-Gahete FJ, Guillén-Riquelme A, Jurado-Fasoli L, Sáez-Roca G, Martín-Carrasco C, Buela-Casal G, Ruiz JR.
JAMA network open · 2022-04-01
DOI: 10.1001/jamanetworkopen.2022.8212 ↗PubMed · 35452108 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
运动改善45岁及以上睡眠障碍者的睡眠质量评分
汇总23项随机对照试验、共1,478名45至77岁睡眠障碍成年人的数据,运动改善了匹兹堡睡眠质量指数评分(SMD 0.62,95%置信区间0.40–0.83),网络分析中有氧运动效果最大(SMD 1.34,95%可信区间0.86–1.82)。证据确定性为低到中等,结局是问卷评分,每周约539 MET-min的最佳剂量是模型估计值,不是处方。
Journal of Exercise Science & Fitness
睡眠规律性比睡眠时长更能预测英国成年人的死亡风险
在60,977名佩戴腕式加速度计一周的英国生物样本库成年人中,睡眠最规律的五分之一人群,经完全校正后的全因死亡风险比为0.70(95%置信区间0.59–0.83),对照为最不规律的五分之一,随访约6.3年,共1859人死亡。规律性对数据的拟合优于睡眠时长,但这是只依据一周数据的观察性研究。
Sleep
延长睡眠使超重成年人每日能量摄入减少约270千卡
在80名平时睡眠不足6.5小时的超重成年人中,两周的延长睡眠指导使睡眠增加约1.2小时,实测能量摄入比对照组少270.4千卡/天(95%置信区间−393.4至−147.4)。这是一项为期短、单中心、人群较窄的试验,不能说明体重会持续下降,也不能说明对睡眠本就充足的人有益。
JAMA Internal Medicine
50岁和60岁时每晚睡6小时及以下,与日后痴呆风险较高相关
在7959名英国公务员中随访约25年,50岁时每晚睡6小时及以下者的痴呆风险比为1.22(95%置信区间1.01–1.48),60岁时为1.37(1.10–1.72),均高于睡7小时者;长期持续睡眠偏短者为1.30(1.00–1.69)。睡眠主要靠自报,且为观察性研究,早期脑部病变等因素可能解释了部分关联。
Nature Communications

